WO2016191835A1 - Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound - Google Patents
Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound Download PDFInfo
- Publication number
- WO2016191835A1 WO2016191835A1 PCT/BR2015/050068 BR2015050068W WO2016191835A1 WO 2016191835 A1 WO2016191835 A1 WO 2016191835A1 BR 2015050068 W BR2015050068 W BR 2015050068W WO 2016191835 A1 WO2016191835 A1 WO 2016191835A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- called
- reaction
- heptane
- give
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC(*)(C1(CC1)CC1)C=C1OC Chemical compound CC(*)(C1(CC1)CC1)C=C1OC 0.000 description 4
- QVHJYXRDSAWVRM-JDOFKEMOSA-N CC1(C)[C@](C)(CC2)[C@@H]1CC2O Chemical compound CC1(C)[C@](C)(CC2)[C@@H]1CC2O QVHJYXRDSAWVRM-JDOFKEMOSA-N 0.000 description 1
- VZTPAWXRVQVKIH-DMRQEDOKSA-N CCC(C(C1)C1(CC)C1)[C@@H](C)C1=O Chemical compound CCC(C(C1)C1(CC)C1)[C@@H](C)C1=O VZTPAWXRVQVKIH-DMRQEDOKSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
- C07C15/20—Polycyclic condensed hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
- C07C15/20—Polycyclic condensed hydrocarbons
- C07C15/38—Polycyclic condensed hydrocarbons containing four rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/48—Preparation of compounds having groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G8/00—Condensation polymers of aldehydes or ketones with phenols only
- C08G8/28—Chemically modified polycondensates
- C08G8/30—Chemically modified polycondensates by unsaturated compounds, e.g. terpenes
Definitions
- the present invention relates to the method of preparing ingenol-5,20-acetonide as well as ingenol-5,20-acetonide obtained by such a process.
- the invention also relates to novel intermediate compounds of the ingenol-5,20-acetonide preparation.
- ingenol-5,20-acetonide An example prior art synthesis of ingenol-5,20-acetonide is shown in patent application WO2012010172, wherein the ingenol compound (CAS # 30220-46-3) is reacted with acetone in the presence of p-toluenesulfonic acid. catalyst followed by neutralization with sodium hydrogen carbonate.
- acetonide is an intermediate in obtaining ingenol-3-angelate, having ingenol as the starting material. This process is unsuitable for scale-up, especially as it cannot prevent a large loss of the precious ingenol raw material in the reaction of obtaining ingenol-5,20-acetonide from ingenol.
- the present invention aims at a state of the art process optimized for obtaining ingenol-5,20-acetonide, particularly suitable for industrial scale production.
- Cryogenic conditions in the following context, unless otherwise stated, refer to typical temperatures between -40 ° C and -80 ° C, and use of suitable equipment for this purpose.
- the present invention aims at obtaining ingenol-5,20-acetonide from the reaction between 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde (hereinafter as compound 9) and 2,2-dimethyl-4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane (hereinafter referred to as compound 19), illustrated below:
- the synthesis of the ingenol-5,20-acetonide compound from compounds 9 and 19 involves a sequence of Wittig reactions, Pauson-Khand cyclization, alkene oxidation, Grignard reaction and a rearrangement of Pinacol.
- Step 1 is a Wittig reaction, also called Wittig olefination, in which compound 9, an aldehyde, reacts with compound 19, a phosphorus ylide called Wittig reagent in organic solution at a high temperature of the order 100 ° C in the presence of strong bases, for example potassium tert-butoxide.
- An alkene - intermediate 1 - and triphenylphosphine oxide to be removed are obtained. Ilet instability results in high prevalence of alkene - ie intermediate 1 - of Z configuration.
- This ring formation step is a addition [2 + 2 + 1] between intermediate 1, an alkene, and carbon monoxide, in the presence of a suitable catalyst, for example a transition metal complex such as dicobalt octacarbonyl Co 2 (CO) 8 , under atmospheric pressure of CO.
- a suitable catalyst for example a transition metal complex such as dicobalt octacarbonyl Co 2 (CO) 8 , under atmospheric pressure of CO.
- This step refers to a dihydroxylation of intermediate 2, which can be done in alternate ways:
- Os0 4 osmium tethoxide
- periodate particularly metaperiodate, or potassium peroxymonosulfate (eg Oxone ® marketed by Dupont de Nemours), in the presence of ruthenium or cerium catalyst under neutral conditions.
- periodate particularly metaperiodate, or potassium peroxymonosulfate (eg Oxone ® marketed by Dupont de Nemours)
- ruthenium or cerium catalyst under neutral conditions.
- Intermediate 3 is identified as (1R, 5R, 6R, 7R, 14S, 15R, 17R, 19R) -1,5,6-trihydroxy-1 H, and g-pentamethyl-S 2 O-dioxapentacyclothiazol. O, 1 .0 2 ⁇ , 2.12 ⁇ nonadeca-dien-4-one.
- Intermediate 4 is identified as (1S, 2R, 9S, 10R, 12R, 14R, 15R, 19R) -15-hydroxy-4,4, H, 11,14-pentamethyl-3,5,20,22-tetraoxahexacyclo [ 14.6.0.0 1, 1 .0 2 .0, 1 1 .0 12] docosahexaenoic 18,21-diene-7,16-dione.
- Step 4 relates to methylation of the cyclopentenone ring with a Grignard reagent, methyl magnesium bromide under cryogenic conditions. This reaction turns ketone on carbon 2 into tertiary alcohol, yielding intermediate 5 of tiglian structure.
- Step 5 is a pinacol rearrangement, in which tertiary alcohol loses the hydroxyl group, generating a carbo-cation at position 2.
- the arrows in the image of intermediate 5 above indicate the parts involved in the transformation.
- the reaction is catalyzed, for example, with boron trifluoride etherate, organoaluminum compounds or any other suitable one.
- Step 3 Removal of the useful diol protection introduced in step 3 by any suitable means, for example by using a base, TBAF (tetrabutylammonium fluoride) or pyridinium hydrofluoride.
- TBAF tetrabutylammonium fluoride
- pyridinium hydrofluoride tetrabutylammonium fluoride
- the present invention further relates to the synthesis of compound 9 used in the synthesis of ingenol-5,20-acetonide described above.
- the reaction of this step is itself known, for example described in Polish J. Chem. 74, 777, 2000, using free radical catalyst such as N-chloro-succinamide (NCS) in the presence of base under argon atmosphere.
- NCS N-chloro-succinamide
- the catalyst base may be 1,4-diazabicyclo [2.2.2] octane (as the DABCO ® commercial product of Air Products), DMAP (4-dimethylaminopyridine), or silica gel.
- compound 2 is ozonolysis in a suitable solvent, particularly aqueous acetone, under cooling.
- This step is a reductive catalytic dechlorination.
- Compound 4 (7,7-dimethylbicyclo [4.1.0] heptane-3-one) is obtained by catalytic hydrogenolysis of compound 3 using a suitable catalyst, for example palladium, under pressure.
- a suitable catalyst for example palladium, under pressure.
- the resulting hydrogen chloride may be collected in situ by carbonate salts.
- Compound 5 This step refers to the hydroxymethylation of compound 5 to give compound 6 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one).
- the reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).
- Compound 7 (2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-one) is obtained by methylation of compound 6, initiated by the transient protective reaction of compound 6 with trimethylsilyl chloride (TMS), TMS enol formation, lithium enol lithium, and subsequent reaction in a vessel with methyl iodate under cryogenic conditions at a temperature of -78 ° C.
- TMS trimethylsilyl chloride
- Compound 9 is obtained by reacting compound 8 with 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3 (1H) -one, the Dess-Martin periodinane reagent.
- steps 3A, 4A, 5A and 6A described above may be replaced by steps 3AA, 4AA and 5AA described below.
- Compound 3 is transformed into Grignard reagent using magnesium followed by reaction with methyl iodide, with or without catalyst, for example NiBr 2 or CuCl 2 to give compound 10, which is 4-methyl-7, 7-dimethylbicyclo [4.1.0] heptane-3-one.
- Compound 11 which is 4-methyl-5-trimethylsilyl 7,7-dimethylbicyclo [4.1.0] -2-hepten-3-ol, a TMS enol, is prepared in a suitable solvent, such as THF, in reaction. of compound 10 with TMS and lithium bis (trimethylsilyl) amide chloride (LiHDMS) under cryogenic conditions at a temperature of -78 ° C.
- a suitable solvent such as THF
- This step refers to the hydroxymethylation of compound 11 to yield compound 7 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one).
- the reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).
- the present invention further relates to the synthesis of compound 19, used in the synthesis of ingenol-5,20-acetonide, described above.
- Compound 19 is obtained from L-serine methyl ester (N-methyl-L-serine).
- compound 13 is reacted with DIBAL (diisobutylaluminum hydride) resulting in compound 14: 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-formyl.
- DIBAL diisobutylaluminum hydride
- compound 13 is subjected to reduction, for example with lithium aluminum hydride or lithium borohydride, followed by oxidation, for example Swern oxidation, or via the use of a suitable bleach such as sodium or calcium hypochlorite, in the presence of catalyst TEMPO (2,2,6,6-tetramethylpiperidinyloxy, CAS No 2564-83-2), resulting compound 14.
- TEMPO 2,2,6,6-tetramethylpiperidinyloxy, CAS No 2564-83-2
- This step is aimed at deprotecting compound 15 to generate compound 16, which is (2S, 3S) -2-amino-1,3-dihydroxy-pent-4-yo, occurs in the presence of aqueous TFA (trifluoroacetic acid) or inorganic acids such as HCl or HBr.
- TFA trifluoroacetic acid
- HCl HCl
- HBr HBr
- Aqueous solution of compound 16 is diazotized in the presence of HBr and KBr to obtain compound 17: (2S, 3S) -2-bromo-1,3-dihydroxy-pent-4-yn.
- the amino group is initially converted to the diazo moiety, which in turn is readily displaced by bromine anions.
- Compound 17 is recovered by extraction in organic solvents.
- Compound 17 is dissolved in a suitable solvent, for example mixture of acetone and 2,2-dimethoxypropane and treated with catalytic amount of sulfonic acid or BF 3 etherate, resulting in compound 18: (2S, 3S) -2-bromo-1,3 -dihydroxy-pent-4-yne acetonide.
- a suitable solvent for example mixture of acetone and 2,2-dimethoxypropane and treated with catalytic amount of sulfonic acid or BF 3 etherate, resulting in compound 18: (2S, 3S) -2-bromo-1,3 -dihydroxy-pent-4-yne acetonide.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
MÉTODO DE PREPARAÇÃO DE INGENOL-5,20-ACETONIDA, MÉTODO DE PREPARAÇÃO DE 3-ETINIL-3-HIDROXI-4.7.7-TRIMETILBICICLO[4.1.0] HEPTANO-2- CARBALDEÍDO, MÉTODO DE PREPARAÇÃO DO COMPOSTO 2,2-DIMETIL-4-ETINIL-5 - TRIFENILFOSFORANILIDENO-l,3-DIOXANO E COMPOSTO INTERMEDIÁRIO INGENOL-5,20-ACETONIDE PREPARATION METHOD, 3-ETHINYL-3-HYDROXI-4.7.7-TRIMETHYLBICICLE PREPARATION METHOD [4.1.0] HEPTAN-2-CARBALDEIDE, COMPOSITE PREPARATION METHOD 2,2-DIMETHYL -4-ETINYL-5 - TRYPHENYLPHOSPHORANYLIDEN-1,3-DIOXANE AND INTERMEDIATE COMPOUND
A presente invenção refere-se a método de preparação de ingenol-5,20- acetonida, assim como ingenol-5,20-acetonida obtida por tal processo. A invenção visa também novos compostos intermediários da preparação de ingenol-5,20- acetonida. The present invention relates to the method of preparing ingenol-5,20-acetonide as well as ingenol-5,20-acetonide obtained by such a process. The invention also relates to novel intermediate compounds of the ingenol-5,20-acetonide preparation.
Antecedentes da Invenção Background of the Invention
lngenol-5,20-acetonida, ilustrada abaixo, identificada pelo número CAS 77573- lngenol-5,20-acetonide, illustrated below, identified by CAS number 77573-
43-4, é composto conhecido como intermediário na síntese de derivados 3-ester de ingenol, entre outras aplicaçõe gem mais longa que ingenol. 43-4, is a compound known as an intermediate in the synthesis of ingenol 3-ester derivatives, among other applications longer than ingenol.
Ingenol-5,20-acetonida Ingenol-5,20-acetonide
Um exemplo de síntese de ingenol-5,20-acetonida do estado da técnica é mostrado no pedido de patente WO2012010172, em que o composto ingenol (no. CAS 30220-46-3) é reagido com acetona em presença de ácido p-toluenosulfônico catalisador, seguindo-se neutralização com hidrogenocarbonato de sódio. No contexto daquele documento, a acetonida é um intermediário na obtenção de ingenol-3- angelato, tendo ingenol como material de partida. Esse processo é inadequado a um aumento de escala, principalmente por não conseguir evitar uma grande perda da preciosa matéria prima ingenol na reação de obtenção de ingenol-5,20-acetonida a partir de ingenol. An example prior art synthesis of ingenol-5,20-acetonide is shown in patent application WO2012010172, wherein the ingenol compound (CAS # 30220-46-3) is reacted with acetone in the presence of p-toluenesulfonic acid. catalyst followed by neutralization with sodium hydrogen carbonate. In the context of that document, acetonide is an intermediate in obtaining ingenol-3-angelate, having ingenol as the starting material. This process is unsuitable for scale-up, especially as it cannot prevent a large loss of the precious ingenol raw material in the reaction of obtaining ingenol-5,20-acetonide from ingenol.
A presente invenção visa um processo otimizado em relação ao estado da técnica, voltado à obtenção de ingenol-5,20-acetonida, particularmente adequado à produção em escala industrial. The present invention aims at a state of the art process optimized for obtaining ingenol-5,20-acetonide, particularly suitable for industrial scale production.
Descrição da Invenção Description of the Invention
Condições criogênicas, no contexto que segue, exceto menção em contrário, refere-se a temperaturas típicas entre -40°C e -80°C, e utilização de equipamentos adequados para esse fim. Cryogenic conditions, in the following context, unless otherwise stated, refer to typical temperatures between -40 ° C and -80 ° C, and use of suitable equipment for this purpose.
A presente invenção visa a obtenção de ingenol-5,20-acetonida a partir da reação entre 3-etinil-3-hidroxi-4.7.7-trimetilbiciclo[4.1.0]heptano-2-carbaldeído (a seguir referido como composto 9) e 2,2-dimetil-4-etinil-5-trifenilfosforanilideno-l,3- dioxano (a seguir referido como composto 19), ilustrados abaixo: The present invention aims at obtaining ingenol-5,20-acetonide from the reaction between 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde (hereinafter as compound 9) and 2,2-dimethyl-4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane (hereinafter referred to as compound 19), illustrated below:
Composto 9 Composto 19 Compound 9 Compound 19
Em um primeiro aspecto da invenção, a síntese do composto ingenol-5,20- acetonida a partir dos compostos 9 e 19 envolve uma sequência das reações de Wittig, ciclização de Pauson-Khand, oxidação de alceno, reação de Grignard e um rearranjo de pinacol. In a first aspect of the invention, the synthesis of the ingenol-5,20-acetonide compound from compounds 9 and 19 involves a sequence of Wittig reactions, Pauson-Khand cyclization, alkene oxidation, Grignard reaction and a rearrangement of Pinacol.
A descrição a seguir ilustra um primeiro aspecto da invenção, qual seja, as etapas de obtenção de ingenol-5,20-acetonida a partir dos compostos 9 e 19 mencionados acima. The following description illustrates a first aspect of the invention, namely the steps of obtaining ingenol-5,20-acetonide from the above mentioned compounds 9 and 19.
Mais adiante serão descritos outros aspectos da invenção, quais sejam, as sínteses de tais compostos 9 e 19 a partir de matérias primas adequadas quanto à disponibilidade comercial abundante e baixo custo, respectivamente (+) 3-careno e metil serina. Further aspects of the invention will be described below, such as syntheses of such compounds 9 and 19 from suitable starting materials for abundant commercial availability and low cost, respectively (+) 3-carene and methyl serine.
Etapa 1 COMPOSTO 9 + COMPOSTO 19 Step 1 9 + 9
Intermediário 1 Intermediate 1
A etapa 1 é uma reação de Wittig, também chamada de olefinação de Wittig, em que o composto 9, um aldeído, reage com o composto 19, um ileto de fósforo, chamado reagente de Wittig, em solução orgânica, em temperatura alta da ordem de 100°C, em presença de bases fortes, por exemplo terc-butóxido de potássio. Obtém-se um alceno - o intermediário 1 - e óxido de trifenilfosfina, a ser eliminada. A instabilidade do ileto resulta em grande prevalência de alceno - ou seja, o intermediário 1 - de configuração Z. Step 1 is a Wittig reaction, also called Wittig olefination, in which compound 9, an aldehyde, reacts with compound 19, a phosphorus ylide called Wittig reagent in organic solution at a high temperature of the order 100 ° C in the presence of strong bases, for example potassium tert-butoxide. An alkene - intermediate 1 - and triphenylphosphine oxide to be removed are obtained. Ilet instability results in high prevalence of alkene - ie intermediate 1 - of Z configuration.
O intermediário 1 é identificado como (lR,2R,3R,4R,6R)-3-ethinil-2-{l-[(4S,5Z)- Intermediate 1 is identified as (1R, 2R, 3R, 4R, 6R) -3-ethinyl-2- {1 - [(4S, 5Z) -
4-ethinil-2,2-dimetil-l,3-dioxan-5-ilideno] etil}-4.7.7-trimetilbiciclo[4.1.0]heptan-3-ol. 4-ethinyl-2,2-dimethyl-1,3-dioxan-5-ylidene] ethyl} -4.7.7-trimethylbicyclo [4.1.0] heptan-3-ol.
Intermediário 1 Intermediário 2 Intermediate 1 Intermediate 2
Esta etapa de formação de anel, uma reação de Pauson-Khand, é uma ciclo- adição [2+2+1] entre o intermediário 1, um alceno, e monóxido de carbono, em presença de catalisador adequado, por exemplo um complexo de metal de transição como dicobalto octacarbonila Co2(CO)8, sob pressão de atmosfera de CO. This ring formation step, a Pauson-Khand reaction, is a addition [2 + 2 + 1] between intermediate 1, an alkene, and carbon monoxide, in the presence of a suitable catalyst, for example a transition metal complex such as dicobalt octacarbonyl Co 2 (CO) 8 , under atmospheric pressure of CO.
O intermediário 2 é identificado como (lR,7S,14S,15R,17R,19R)-l-hidroxi- 9,9,16,16,19-pentametil-8,10-dioxapentaciclo[12.5.0.02,.0,12.0V] nonadeca-2,5,12- trien-4-ona. Intermediate 2 is identified as (1R, 7S, 14S, 15R, 17R, 19R) -1-hydroxy-9,9,16,16,19-pentamethyl-8,10-dioxapentacyclo [12.5.0.0 2 , .0, 12 .0V] nonadeca-2,5,12- trien-4-one.
Etapa 3 Step 3
Intermediário 2 Intermediário 3 Intermediate 2 Intermediate 3
Esta etapa refere-se a uma diidroxilação do intermediário 2, que pode ser feita de maneiras alternativas: This step refers to a dihydroxylation of intermediate 2, which can be done in alternate ways:
- via uma reação de osmilação, catalisada com tetróxido de ósmio (Os04), por exemplo em solução ou suportado em um polímero; via an osmylation reaction, catalyzed with osmium tethoxide (Os0 4 ), for example in solution or supported on a polymer;
- via reação com periodato, particularmente metaperiodato, ou peroximonosulfato de potássio (por exemplo Oxone® comercializado por Dupont de Nemours), em presença de catalisador de rutênio ou cério sob condições neutras. - via reaction with periodate, particularly metaperiodate, or potassium peroxymonosulfate (eg Oxone ® marketed by Dupont de Nemours), in the presence of ruthenium or cerium catalyst under neutral conditions.
A subsequente proteção dos dióis eis, mostrada abaixo, é efetuada utilizando bis-imidazolil carbonato ou reagentes sililantes. Subsequent protection of useful diols, shown below, is performed using bisimidazolyl carbonate or silylating reagents.
Intermediário 3 Intermediário 4Intermediate 3 Intermediate 4
O intermediário 3 é identificado como (1R,5R,6R,7R,14S,15R,17R,19R)-1,5,6- triidroxi-^^ie^e g-pentametil-S^O-dioxapentaciclotlZ.S.O.O^.O,1 2.0Ί , ^nonadeca- 2,12-dien-4-ona. Intermediate 3 is identified as (1R, 5R, 6R, 7R, 14S, 15R, 17R, 19R) -1,5,6-trihydroxy-1 H, and g-pentamethyl-S 2 O-dioxapentacyclothiazol. O, 1 .0 2 Ί, 2.12 ^ nonadeca-dien-4-one.
O intermediário 4 é identificado como (1S,2R,9S,10R,12R,14R,15R,19R)-15- hidroxi-4,4,H,ll,14-pentametil-3,5,20,22-tetraoxahexaciclo[14.6.0.01,1.02,.0,1.01,12] docosa-7,16-dieno-18,21-diona. Intermediate 4 is identified as (1S, 2R, 9S, 10R, 12R, 14R, 15R, 19R) -15-hydroxy-4,4, H, 11,14-pentamethyl-3,5,20,22-tetraoxahexacyclo [ 14.6.0.0 1, 1 .0 2 .0, 1 1 .0 12] docosahexaenoic 18,21-diene-7,16-dione.
Etapa 4 Step 4
Intermediário 4 Intermediário 5 Intermediate 4 Intermediate 5
A etapa 4 refere-se à metilação do anel ciclopentenona com um reagente de Grignard, brometo de metil magnésio sob condições criogênicas. Esta reação transforma a cetona no carbono 2 em álcool terciário, originando o intermediário 5 de estrutura de tigliano. Step 4 relates to methylation of the cyclopentenone ring with a Grignard reagent, methyl magnesium bromide under cryogenic conditions. This reaction turns ketone on carbon 2 into tertiary alcohol, yielding intermediate 5 of tiglian structure.
O intermediário 5 é identificado como (1S,2R,9S,10R,12R,14R,15R,18R,19S)- 15,18-diidroxi-4,4,ll,ll,14,18-hexametil-3,5,20,22-tetraoxahexaciclo Intermediate 5 is identified as (1S, 2R, 9S, 10R, 12R, 14R, 15R, 18R, 19S) -15,18-dihydroxy-4,4,11,11,11,18-hexamethyl-3,5, 20,22-tetraoxahexacyclo
[14.6.0.01,1.02,.0,1.01,12] docosa-7,16-dien-21-ona. Etapa 5 [14.6.0.0 1, 1 .0 2 .0, 1 1 .0 12] docosahexaenoic 7,16-dien-21-one. Step 5
Intermediário 5 Intermediário 6 Intermediate 5 Intermediate 6
A etapa 5 é um rearranjo de pinacol, em que o álcool terciário perde o grupo hidroxila, gerando uma carbo-cátion na posição 2. As setas na imagem do intermediário 5 acima indicam as partes envolvidas na transformação. A reação é catalisada, por exemplo, com trifluoreto de boro eterato, compostos de organoalumínio ou qualquer outro adequado. Step 5 is a pinacol rearrangement, in which tertiary alcohol loses the hydroxyl group, generating a carbo-cation at position 2. The arrows in the image of intermediate 5 above indicate the parts involved in the transformation. The reaction is catalyzed, for example, with boron trifluoride etherate, organoaluminum compounds or any other suitable one.
O intermediário 6 é identificado como (1S,4S,8S,9R,16S,17R,19R,21R)- 3,ll,ll,18,18,21-hexametil-5,7,10,12-tetraoxahexaciclo[14.5.1.01,.0,.0,1.0V]docosa-Intermediate 6 is identified as (1S, 4S, 8S, 9R, 16S, 17R, 19R, 21R) -3,11,11,18,18,21-hexamethyl-5,7,10,12-tetraoxahexacyclo [14.5. 1.0 1 .0, .0, 1 .0V] docosahexaenoic
2,14-dieno-6,22-diona. 2,14-diene-6,22-dione.
Etapa 6 Step 6
Trata-se da remoção da proteção aos dióis eis, introduzida na etapa 3, por qualquer meio adequado, por exemplo empregando-se uma base, TBAF (fluoreto de tetrabutilamônio) ou hidrofluoreto de piridínio. Removal of the useful diol protection introduced in step 3 by any suitable means, for example by using a base, TBAF (tetrabutylammonium fluoride) or pyridinium hydrofluoride.
Intermediário 6 ingenol-5,20-acetonida Dentro de aspecto adicional, a invenção refere-se aos compostos intermediários numerados de 1 a 6, dentro da sequência de etapas de obtenção ingenol-5,20-acetonida, retro-descritas. Intermediate 6 ingenol-5,20-acetonide In a further aspect, the invention relates to intermediate compounds numbered from 1 to 6 within the sequence of ingenol-5,20-acetonide obtaining steps described above.
Obtenção do Composto 9 Obtaining Compound 9
A presente invenção refere-se adicionalmente à síntese do composto 9, utilizado na síntese de ingenol-5,20-acetonida, já descrita mais atrás. The present invention further relates to the synthesis of compound 9 used in the synthesis of ingenol-5,20-acetonide described above.
Composto 1 Composto 2 Compound 1 Compound 2
Trata-se de uma etapa de cloração do (+)-3- careno (composto 1), obtendo-se trans-4-cloro-3-careno (composto 2). A reação desta etapa é em si conhecida, por exemplo descrita em Polish J. Chem. 74, 777, 2000, utilizando catalisador de radicais livres, como N-cloro-succinamida (NCS) em presença de base, sob atmosfera de argônio. This is a chlorination step for (+) -3-carene (compound 1) to give trans-4-chloro-3-carene (compound 2). The reaction of this step is itself known, for example described in Polish J. Chem. 74, 777, 2000, using free radical catalyst such as N-chloro-succinamide (NCS) in the presence of base under argon atmosphere.
A base do catalisador pode ser l,4-diazabiciclo[2.2.2]octano (como o produto comercial DABCO®, da empresa Air Products), DMAP (4-dimetilaminopiridina), ou sílica gel. The catalyst base may be 1,4-diazabicyclo [2.2.2] octane (as the DABCO ® commercial product of Air Products), DMAP (4-dimethylaminopyridine), or silica gel.
Etapa 2A Step 2A
Composto 2 Composto 3 Compound 2 Compound 3
Nesta etapa, para obtenção do composto 3, 4-cloro-7,7- dimetilbiciclo[4.1.0]heptano-3-ona), faz-se a ozonólise do composto 2, em solvente adequado, particularmente acetona aquosa, sob resfriamento. In this step, to obtain compound 3,4-chloro-7,7-dimethylbicyclo [4.1.0] heptane-3-one), compound 2 is ozonolysis in a suitable solvent, particularly aqueous acetone, under cooling.
Eventuais peróxidos residuais são reagidos com dimetilsulfeto antes da remoção da acetona. Possible residual peroxides are reacted with dimethyl sulfide prior to acetone removal.
Etapa 3 A Step 3 A
Composto 3 Composto 4 Compound 3 Compound 4
Esta etapa é uma descloração catalítica redutiva. O composto 4 (7,7- dimetilbiciclo[4.1.0]heptano-3-ona) é obtido por hidrogenólise catalítica do composto 3, empregando-se catalisador adequado, por exemplo de paládio, sob pressão. O cloreto de hidrogénio resultante pode ser recolhido in situ por sais de carbonato. This step is a reductive catalytic dechlorination. Compound 4 (7,7-dimethylbicyclo [4.1.0] heptane-3-one) is obtained by catalytic hydrogenolysis of compound 3 using a suitable catalyst, for example palladium, under pressure. The resulting hydrogen chloride may be collected in situ by carbonate salts.
Etapa 4 Step 4
Composto 4 Composto 5 Compound 4 Compound 5
A reação de obtenção do composto 5 (trimetilsilil 7,7-dimetilbiciclo[4.1.0]2- hepteno-3-ol) a partir do composto 4 é, em sua generalidade, conhecida do estado da técnica, por exemplo o artigo de A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), utilizando cloreto de TMS (trimetilsilila) e lítio bis(trimetilsilil)amida (LiHMDS ) em tetraidrofurano (THF) em condições criogênicas, em temperatura da ordem de -78° C. Etapa 5 A The reaction of obtaining compound 5 (trimethylsilyl 7,7-dimethylbicyclo [4.1.0] 2-hepten-3-ol) from compound 4 is generally known in the art, for example the article in A Sekine et al. (Tetrahedron Letters 41 (2000) 509) using TMS (trimethylsilyl) and lithium bis (trimethylsilyl) amide (LiHMDS) chloride in tetrahydrofuran (THF) under cryogenic conditions at a temperature of -78 ° C. Step 5 A
Composto 5 Composto 6 Esta etapa refere-se à hidroximetilação do composto 5 para gerar o composto 6 (2-hidroximetil-7,7-dimetilbiciclo[4.1.0]heptano-3-ona). A reação é também conhecida, por exemplo como revelado no artigo já mencionado de A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), realizada com formaldeído em presença de Yb(OTf)3 (trifluorometanosulfonato de itérbio III). Compound 5 Compound 6 This step refers to the hydroxymethylation of compound 5 to give compound 6 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one). The reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).
Etapa 6A Step 6A
Composto 6 Composto 7 Compound 6 Compound 7
O composto 7 (2-hidroximetil-4.7.7-trimetilbiciclo[4.1.0]heptano-3-ona) é obtido por metilação do composto 6, iniciada com a reação de proteção transitória do composto 6 com cloreto de trimetilsilila (TMS), formação de TMS enol, litiação do enol com metil lítio, e subsequente reação em um vaso com metil iodato em condições criogênicas, em temperatura da ordem de -78°C. Compound 7 (2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-one) is obtained by methylation of compound 6, initiated by the transient protective reaction of compound 6 with trimethylsilyl chloride (TMS), TMS enol formation, lithium enol lithium, and subsequent reaction in a vessel with methyl iodate under cryogenic conditions at a temperature of -78 ° C.
Etapa 7A Step 7A
Composto 7 Composto 8 Compound 7 Compound 8
O composto 8 (3-etinil-2-hiydroximetil-4.7.7-trimetilbiciclo [4.1.0] heptano-3-ol) é obtido reagindo-se o composto 7 com excesso de brometo de etinilmagnésio em solvente como THF em condições criogênicas, em temperatura da ordem de -78 C. Etapa 8A Compound 8 (3-ethynyl-2-hydroxymethyl-4,7,7-trimethylbicyclo [4.1.0] heptane-3-ol) is obtained by reacting compound 7 with excess ethinylmagnesium bromide in solvent as THF under cryogenic conditions, at a temperature of -78 ° C. Step 8A
Composto 8 Composto 9 Compound 8 Compound 9
A obtenção do composto 9 ocorre pela reação do composto 8 com 1,1,1- triacetoxi-l,l-diidro-l,2-benziodoxol-3(lH)-ona, o reagente de Dess-Martin periodinano. Compound 9 is obtained by reacting compound 8 with 1,1,1-triacetoxy-1,1-dihydro-1,2-benziodoxol-3 (1H) -one, the Dess-Martin periodinane reagent.
De forma alternativa, as etapas 3A, 4A, 5A e 6A acima descritas podem ser substituídas pelas etapas 3AA, 4AA e 5AA, descritas a seguir. Alternatively, steps 3A, 4A, 5A and 6A described above may be replaced by steps 3AA, 4AA and 5AA described below.
Etapa 3AA Step 3AA
Composto 3 Composto 10Compound 3 Compound 10
O composto 3 é transformado em reagente de Grignard utilizando-se magnésio, seguindo-se reação com iodeto de metila, com ou sem catalisador, por exemplo NiBr2 ou CuCI2, dando origem ao composto 10, que é 4-metil-7,7- dimetilbiciclo[4.1.0]heptano-3-ona. Compound 3 is transformed into Grignard reagent using magnesium followed by reaction with methyl iodide, with or without catalyst, for example NiBr 2 or CuCl 2 to give compound 10, which is 4-methyl-7, 7-dimethylbicyclo [4.1.0] heptane-3-one.
Etapa 4AA Step 4AA
Composto 10 Composto 11Compound 10 Compound 11
O composto 11, qual seja 4-metil-5-trimetilsilil 7,7-dimetilbiciclo[4.1.0]-2- hepteno-3-ol, um TMS enol, é preparado em solvente adequado, como THF, em reação do composto 10 com cloreto de TMS e lítio bis(trimetilsilil)amida (LiHDMS) em condições criogênicas, em temperatura da ordem de -78°C. Compound 11, which is 4-methyl-5-trimethylsilyl 7,7-dimethylbicyclo [4.1.0] -2-hepten-3-ol, a TMS enol, is prepared in a suitable solvent, such as THF, in reaction. of compound 10 with TMS and lithium bis (trimethylsilyl) amide chloride (LiHDMS) under cryogenic conditions at a temperature of -78 ° C.
Etapa 5AA Step 5AA
Composto 11 Composto 7 Compound 11 Compound 7
Esta etapa refere-se à hidroximetilação do composto 11 para gerar o composto 7 (2-hidroximetil-7,7-dimetilbiciclo[4.1.0]heptano-3-ona). A reação é também conhecida, por exemplo como revelado no artigo já mencionado de A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), realizada com formaldeído em presença de Yb(OTf)3 (trifluorometanosulfonato de itérbio III). This step refers to the hydroxymethylation of compound 11 to yield compound 7 (2-hydroxymethyl-7,7-dimethylbicyclo [4.1.0] heptane-3-one). The reaction is also known, for example as disclosed in the aforementioned article by A. Sekine et al. (Tetrahedron Letters 41 (2000) 509), performed with formaldehyde in the presence of Yb (OTf) 3 (ytterbium trifluoromethanesulfonate III).
Obtenção do Composto 19 Obtaining Compound 19
A presente invenção refere-se adicionalmente à síntese do composto 19, utilizado na síntese de ingenol-5,20-acetonida, já descrita mais atrás The present invention further relates to the synthesis of compound 19, used in the synthesis of ingenol-5,20-acetonide, described above.
A obtenção do composto 19 se dá a partir do éster metílico de L-serina (N- metil-L-serina). Compound 19 is obtained from L-serine methyl ester (N-methyl-L-serine).
Obs: Boc = terc-butoxi carbonila Note: Boc = tert-butoxy carbonyl
Etapa 1B Step 1B
Composto 12 Composto 13Compound 12 Compound 13
Reação do éster metílico de L-serina, denominado composto 12, com anidrido de terc-butoxi carbonila em presença de trietilamina, resultando éster metílico de Boc- L-serina, o qual, em solvente adequado, particularmente acetona, é reagido com 2,2- dimetoxipropano em presença de quantidade catalítica de trifluoreto de boro eterato, resultando o composto 13: 3-Boc-2,2-dimetil-l,3-oxazolidina-4-carboxilato Reaction of L-serine methyl ester, named compound 12, with anhydride of tert-butoxycarbonyl in the presence of triethylamine, resulting in Boc-L-serine methyl ester which, in a suitable solvent, particularly acetone, is reacted with 2,2-dimethoxypropane in the presence of catalytic amount of boron trifluoride etherate, resulting compound 13: 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-carboxylate
Etapa 2B Step 2B
Composto 13 Composto 14Compound 13 Compound 14
O composto 13 é reagido com DIBAL (hidreto de diisobutilalumínio) resultando o composto 14: 3-Boc-2,2-dimetil-l,3-oxazolidina-4-formila. Alternativamente, submete-se o composto 13 a uma redução, por exemplo com hidreto de lítio alumínio ou boroidreto de lítio, seguida de oxidação, por exemplo uma oxidação de Swern, ou via uso de um alvejante adequado, como hipoclorito de sódio ou cálcio, em presença de catalisador TEMPO (2,2,6,6-tetrametilpiperidiniloxi, número CAS 2564-83-2 ), resultando o composto 14. Compound 13 is reacted with DIBAL (diisobutylaluminum hydride) resulting in compound 14: 3-Boc-2,2-dimethyl-1,3-oxazolidine-4-formyl. Alternatively, compound 13 is subjected to reduction, for example with lithium aluminum hydride or lithium borohydride, followed by oxidation, for example Swern oxidation, or via the use of a suitable bleach such as sodium or calcium hypochlorite, in the presence of catalyst TEMPO (2,2,6,6-tetramethylpiperidinyloxy, CAS No 2564-83-2), resulting compound 14.
Etapa 3B Step 3B
Composto 14 Composto 15Compound 14 Compound 15
Reação do composto 14 com brometo de magnésio acetileno ou lítio acetilida em meio solvente adequado, por exemplo, THF ou etil éter, preferivelmente conduzida sob condições criogênicas. Resulta um composto 15: Boc-(2S,3S)-2-Amino-1.3-diidroxi- pent-4-ina-l,2-acetal Reaction of compound 14 with magnesium acetylene bromide or lithium acetylide in a suitable solvent medium, for example THF or ethyl ether, preferably conducted under cryogenic conditions. A compound 15 is obtained: Boc- (2S, 3S) -2-Amino-1,3-dihydroxy- pent-4-yn-1,2-acetal
Etapa 4B Step 4B
Composto 15 Composto 16Compound 15 Compound 16
Esta etapa visa a desproteção do composto 15, para gerar o composto 16, qual seja (2S,3S)-2-amino-l,3-dihidroxi-pent-4-ino, ocorre em presença de TFA (ácido trifluoroacético) aquoso ou ácidos inorgânicos como HCI ou HBr. O material em solução aquosa é utilizado diretamente na próxima etapa. This step is aimed at deprotecting compound 15 to generate compound 16, which is (2S, 3S) -2-amino-1,3-dihydroxy-pent-4-yo, occurs in the presence of aqueous TFA (trifluoroacetic acid) or inorganic acids such as HCl or HBr. The aqueous solution material is used directly in the next step.
Etapa 5B Step 5B
Composto 16 Composto 17 Compound 16 Compound 17
Solução aquosa do composto 16 é diazotizada em presença de HBr e KBr, para obter o composto 17: (2S,3S)-2-bromo-l,3-diidróxi-pent-4-ino. O grupo amino é convertido inicialmente à fração diazo, que por sua vez é prontamente deslocada por ânions bromo. O composto 17 é recuperado por extração em solventes orgânicos. Etapa 6B Aqueous solution of compound 16 is diazotized in the presence of HBr and KBr to obtain compound 17: (2S, 3S) -2-bromo-1,3-dihydroxy-pent-4-yn. The amino group is initially converted to the diazo moiety, which in turn is readily displaced by bromine anions. Compound 17 is recovered by extraction in organic solvents. Step 6B
Composto 17 Composto 18 Compound 17 Compound 18
O composto 17 é dissolvido em solvente adequado, por exemplo, mistura de acetona e 2,2-dimetóxipropano e tratado com quantidade catalítica de ácido sulfônico ou BF3 eterato, resultando um composto 18: (2S,3S)-2-bromo-1.3-diidróxi-pent-4-ino acetonida. Compound 17 is dissolved in a suitable solvent, for example mixture of acetone and 2,2-dimethoxypropane and treated with catalytic amount of sulfonic acid or BF 3 etherate, resulting in compound 18: (2S, 3S) -2-bromo-1,3 -dihydroxy-pent-4-yne acetonide.
Etapa 7B Step 7B
Composto 18 Composto 19 Compound 18 Compound 19
Nesta etapa, para chegar ao composto 19 na sua forma ileto, após proteção do acetileno com TMS, o composto 18 é reagido com trifenilfosfina para formar o sal trifenilfosfônio. Para formar o reagente de Wittig, o sal fosfônio é suspenso em solvente adequado, como dietil éter ou THF e tratado com base forte, por exemplo, terc-butóxido de potássio, butil-lítio ou fenil-lítio. In this step, to reach compound 19 in its ylide form, after protection of acetylene with TMS, compound 18 is reacted with triphenylphosphine to form the triphenylphosphonium salt. To form Wittig's reagent, the phosphonium salt is suspended in a suitable solvent such as diethyl ether or THF and treated with a strong base, for example potassium tert-butoxide, butyllithium or phenyl lithium.
O homem da técnica, a partir dos ensinamentos aqui contidos, saberá propor realizações de maneiras não expressamente previstas aqui, mas com função e resultado, em cada etapa, da mesma natureza, estando assim tais realizações englobadas pelas reivindicações anexas. The person skilled in the art, from the teachings herein, will know how to propose embodiments in ways not expressly provided herein, but with function and result, at each stage, of the same nature, and thus such embodiments are encompassed by the appended claims.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BR2015/050068 WO2016191835A1 (en) | 2015-06-03 | 2015-06-03 | Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BR2015/050068 WO2016191835A1 (en) | 2015-06-03 | 2015-06-03 | Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016191835A1 true WO2016191835A1 (en) | 2016-12-08 |
Family
ID=57439755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BR2015/050068 Ceased WO2016191835A1 (en) | 2015-06-03 | 2015-06-03 | Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2016191835A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012010172A1 (en) * | 2010-07-20 | 2012-01-26 | Leo Pharma A/S | A method of producing ingenol-3-angelate |
| WO2012085189A1 (en) * | 2010-12-22 | 2012-06-28 | Leo Pharma A/S | Ingenol-3-acylates i |
| WO2012083953A1 (en) * | 2010-12-22 | 2012-06-28 | Leo Pharma A/S | Ingenol-3-acylates iii and ingenol-3-carbamates |
| WO2014001215A2 (en) * | 2012-06-26 | 2014-01-03 | Leo Laboratories Limited | 3-o-heteroaryl-ingenol |
-
2015
- 2015-06-03 WO PCT/BR2015/050068 patent/WO2016191835A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012010172A1 (en) * | 2010-07-20 | 2012-01-26 | Leo Pharma A/S | A method of producing ingenol-3-angelate |
| WO2012085189A1 (en) * | 2010-12-22 | 2012-06-28 | Leo Pharma A/S | Ingenol-3-acylates i |
| WO2012083953A1 (en) * | 2010-12-22 | 2012-06-28 | Leo Pharma A/S | Ingenol-3-acylates iii and ingenol-3-carbamates |
| WO2014001215A2 (en) * | 2012-06-26 | 2014-01-03 | Leo Laboratories Limited | 3-o-heteroaryl-ingenol |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Davis et al. | Asymmetric oxidation of ester and amide enolates using new (camphorylsulfonyl) oxaziridines | |
| EP3689881B1 (en) | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b | |
| Ireland et al. | An approach to the total synthesis of aplysiatoxin | |
| Bantreil et al. | Copper-Catalyzed Direct Synthesis of Benzamides from Alcohols and Amines. | |
| ES2972431T3 (en) | Procedure involving olefin cross metathesis | |
| EP3297983B1 (en) | Process for preparing a macrocyclic diketone | |
| KR102793118B1 (en) | Process for the preparation of carboprost and its tromethamine salt | |
| Hara et al. | Difluorination of alkenes with iodotoluene difluoride | |
| CA2909209A1 (en) | 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof | |
| CN108713015A (en) | Preparation of macrolides | |
| Casey et al. | Stereochemistry of the degenerate metathesis of terminal alkenes-the nature of the chain-carrying metal-carbene complex | |
| Zhang et al. | An efficient cis-reduction of alkyne to alkene in the presence of a vinyl iodide: stereoselective synthesis of the C22–C31 fragment of leiodolide A | |
| WO2016191835A1 (en) | Method for preparing ingenol-5,20-acetonide, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane and intermediate compound | |
| WO2008081191A1 (en) | Improved method for the wittig reaction in the preparation of carboprost | |
| WO2016191837A1 (en) | Method for preparing ingenol-3-hexanoate, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, and method for preparing the compound 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane | |
| WO2016191836A1 (en) | Method for preparing ingenol-3-dodecanoate, method for preparing 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptane-2-carbaldehyde, and method for preparing 2,2-dimethyl-4-ethynyl-5-triphenylphosphorus anylidene-1,3-dioxane | |
| Davies et al. | Double diastereoselective SuperQuat glycolate aldol reactions: Application to the asymmetric synthesis of polyfunctionalised lactones | |
| BR102014013462A2 (en) | ingenol-5,20-acetonide preparation method, preparation method of 3-ethynyl-3-hydroxy-4,7,7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde, preparation method of 2,2-dimethyl compound -4-ethynyl-5-triphenylphosphoranylidene-1,3-dioxane and intermediate | |
| BR102014013459A2 (en) | ingenol-3-dodecanoate preparation method, preparation method of 3-ethynyl-3-hydroxy-4,7.7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde and preparation method of 2,2-dimethyl-4-one ethinyl-5-triphenylphosphoranylidene-1,3-dioxane | |
| BR102014013457A2 (en) | ingenol-3-hexanoate preparation method, preparation method of 3-ethynyl-3-hydroxy-4,7.7-trimethylbicyclo [4.1.0] heptane-2-carbaldehyde and preparation method of 2,2-dimethyl-4 compound -etinyl-5-triphenylphosphoranylidene-1,3-dioxane | |
| Hilt et al. | Cobalt-catalysed hydrovinylation as the key step in a short synthesis of moenocinol | |
| Xu et al. | Synthesis of chiral heterocyclic compounds via zirconium-catalyzed asymmetric carboalumination of alkenes (ZACA reaction) | |
| NO157414B (en) | PROCEDURE FOR THE PREPARATION OF CARBOXYLIC ACIDS AND ESTERS THEREOF. | |
| CN115181015A (en) | Synthetic method of tri-substituted perfluoroalkylated ketene compounds | |
| JP4910150B2 (en) | A method for producing a β-fluoro (phenylsulfonyl) methyl adduct and a method for producing an optically active β-fluoromethylcarbonyl derivative. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15893553 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 15893553 Country of ref document: EP Kind code of ref document: A1 |